Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
June 1, 2016Company with research operations in US and Israel seeks to develop first-in-class drug to decrease the risk of suicide in those suffering from depressionTEL AVIV, Israel - NeuroRx, a clinical-stage pharmaceutical company developing a first-in-class potentially breakthrough drug for the prevention of suicide in bipolar depression, was awarded first...
-
October 21, 2015Findings note the transient nature of ketamine effects and paucity of promising experimental NMDA antagonists
The active ingredient of Cyclurad™ by NeuroRx, Inc has been identified as potentially promising in the treatment of depression in this month's report by the American Psychiatric Association Task...
-
June 24, 2015Journal of Clinical Psychiatry publishes initial report of human study which showed 50% reduction in symptoms of depression and 75% reduction in suicidality
NeuroRx, Inc., a clinical phase pharmaceutical company, reports first-in-man efficacy data for a newly-purposed class of drugs targeted towards rapidly reducing symptoms of depression and...
-
June 24, 2013Include multimedia assets in your release for better visibility
Educating your customers and prospects by sharing expertise and insight is at the heart of content marketing. According to a recent article by Joe Pulizzi,...
-
March 1, 2011Use This To Test Potential Limitations With Your Site Design
ACME Inc. (NYSE: ) today reported financial results for the fourth quarter and full year ended December 31, 2010. For the fourth quarter 2010, we...
Click here to view our corporate presentation or on the image below
 |
